These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2785970)

  • 41. Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production.
    Hajoui O; Janani R; Tulic M; Joubert P; Ronis T; Hamid Q; Zheng H; Mazer BD
    J Allergy Clin Immunol; 2004 Sep; 114(3):657-63. PubMed ID: 15356573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.
    Gordon J; Rowe M; Walker L; Guy G
    Eur J Immunol; 1986 Sep; 16(9):1075-80. PubMed ID: 2428624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on difference in cellular immune-response between the human tonsil and blood lymphocytes.
    Sugiyama M; Yamamoto K; Kinoshita Y; Kimura S
    Acta Otolaryngol; 1976; 82(5-6):440-50. PubMed ID: 136859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of TPA (12-O-tetradodecanoyl-phorbol-13-acetate) on human B lymphocyte function.
    Falcioni F; Rautmann A; Berg PA; Gross WL
    Clin Exp Immunol; 1985 Dec; 62(3):613-21. PubMed ID: 3878751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
    Rousset F; Garcia E; Defrance T; Péronne C; Vezzio N; Hsu DH; Kastelein R; Moore KW; Banchereau J
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1890-3. PubMed ID: 1371884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and function of DRC-1 antigen.
    Bosseloir AL; Antoine N; Heinen E; DeFrance T; Schuurman H; Simar L
    Adv Exp Med Biol; 1994; 355():243-8. PubMed ID: 7535974
    [No Abstract]   [Full Text] [Related]  

  • 47. Responses of human B-cells to recombinant lymphokines.
    Gallagher G; Taylor N; Willdridge J; Christie JF; Stimson WH
    Dev Biol Stand; 1988; 69():65-73. PubMed ID: 3265680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
    Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
    J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of tumor necrosis factor alpha on mitogen-activated human B cells.
    Kehrl JH; Miller A; Fauci AS
    J Exp Med; 1987 Sep; 166(3):786-91. PubMed ID: 3040886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin.
    Roifman CM; Benedict SH; Cheung RK; Gelfand EW
    Eur J Immunol; 1987 May; 17(5):701-6. PubMed ID: 3495445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoxygenase inhibitors enhance the proliferation of human B cells.
    Behrens TW; Lum LG; Lianos EA; Goodwin JS
    J Immunol; 1989 Oct; 143(7):2285-94. PubMed ID: 2506281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human interleukin 7 is a B cell growth factor for activated B cells.
    Joshi PC; Choi YS
    Eur J Immunol; 1991 Mar; 21(3):681-6. PubMed ID: 1826263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
    Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
    J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of protein synthesis profiles in chronic lymphocytic leukaemia cells and B-lymphocytes from peripheral blood, cord blood and tonsil.
    Saunders FK; Lawry J; Winfield DA; Goepel JR; Hancock BW; Sharrard RM; Goyns MH
    Experientia; 1994 May; 50(5):493-6. PubMed ID: 7515011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of human T and B lymphocytes by polyclonal mitogens.
    Greaves MF; Janossy G; Doenhoff M
    Nature; 1974 Apr; 248(5450):698-701. PubMed ID: 4545414
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro immunization of human tonsilar lymphocytes: effects of PWM and rIL-6.
    Carroll K; Prosser E; O'Kennedy R
    Hybridoma; 1991 Apr; 10(2):229-39. PubMed ID: 1874516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes.
    Morgan JW; Morgan DM; Lasky SR; Ford D; Kouttab N; Maizel AL
    J Immunol; 1996 Oct; 157(7):2900-8. PubMed ID: 8816395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Over-expression of the functional interleukin-11 alpha receptor in the development of B-cell chronic lymphocytic leukemia.
    Tsimanis A; Shvidel L; Klepfish A; Shtalrid M; Kalinkovich A; Berrebi A
    Leuk Lymphoma; 2001 Jun; 42(1-2):195-205. PubMed ID: 11699207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
    Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.